Maxime Dely: How Artificial Intelligence Will Revolutionize Transfusion Safety
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared on LinkedIn:
”From bag to patient: How artificial intelligence will revolutionize transfusion safety
Artificial intelligence won’t save lives on its own — not yet. But soon, it will learn to, quietly, behind the scenes of hospitals. And in the world of blood transfusion, its impact will be profound.
Every second, blood bags will continue to save lives.
But behind each transfusion will remain a complex equation: compatibility, urgency, availability, traceability… and the persistent risk of human error.
What if AI became our greatest ally in making all this safer?
In the coming years, AI will enter the transfusion chain:
- Predictive analysis of needs to prevent shortages
- Automated detection of anomalies in biological data
- Intelligent matching to minimize rare incompatibilities
Where technicians once relied solely on experience and intuition,
AI will step in — not to replace, but to reinforce human vigilance.
Soon, blood bank organizations and hospitals will deploy models capable of:
- Anticipating peaks in blood demand
- Predicting high-risk transfusions before they occur
But beyond technology, a deeper question will emerge — one of trust and ethics:
How will algorithms and human judgment coexist in a field where every drop counts?
So, what do you think — will AI become a cornerstone of transfusion safety, or remain just a supporting tool?”
Stay updated with Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID